Buy & Sell Amphastar Pharmaceuticals Inc (AMPH) – Amphastar Pharmaceuticals Inc Price Today
Key Stats
- $830.93MMarket Cap
- HealthSector
- -29.8%3M Drawdown
- $1.23BEnterprise Value
- -Dividend Yield
- 12 daysTypical Hold Time
Amphastar Pharmaceuticals Inc (AMPH) is currently valued at a market capitalization of $830.93M, with an enterprise value of $1.23B. Over the past 52 weeks, Amphastar Pharmaceuticals Inc has traded between a low of $16.87 and a high of $30.81, highlighting its annual price range. Over the past three months, Amphastar Pharmaceuticals Inc has recorded a drawdown of -29.8%, reflecting recent price volatility. On average, investors hold Amphastar Pharmaceuticals Inc for approximately 12 days, indicating typical investor behavior on the platform.
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Most Recent News
Stock and oil futures open as Iran war enters fourth month with no resolution.
Stock and oil futures began trading as the conflict in Iran entered its fourth month without any signs of resolution. The ongoing war continues to influence market sentiment and commodity prices, keeping investors cautious. Traders will be watching f...

CAPHRA urges full stakeholder inclusion in Asia Pacific tobacco control policies for better public health outcomes.
The Coalition of Asia Pacific Harm Reduction Advocates (CAPHRA) released a position paper calling for formal inclusion of all key stakeholders in tobacco control policy-making across the Asia Pacific. They argue that policies made without meaningful ...

Diana Shipping pushes to replace Genco's board with six independent nominees amid takeover bid.
Diana Shipping, the largest shareholder of Genco Shipping & Trading, has sent an open letter urging Genco shareholders to elect six independent director nominees at the upcoming annual meeting. Diana criticizes the current Genco board for prioritizin...
